Global Export Network Trusted supplier across Africa, CIS, Asia-Pacific, and Latin America
Because AOD 9604 has not completed the full clinical development pathway, its comprehensive side-effect profile in humans is not well characterised and should not be assumed to be benign
AOD 9604 is not FDA-approved for fat loss or any other indication
Developed to target the cytosolic enzyme nicotinamide N-methyltransferase (NNMT), 5-Amino-1MQ serves as a highly specialized molecular probe designed to study the regulation of energy homeostasis, macromolecular metabolism, and epigenetic signaling networks within mammalian tissue models, particularly white adipose tissue (WAT)
Since these guidelines are preliminary, researchers should conduct initial dose-finding studies to identify the optimal range for their specific models
Why Choose The Wellness NPs